Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 04 sector : Health technology save search
vTv Therapeutics Announces 2021 Second Quarter Financial Results and Provides Corporate Update
Published: 2021-08-04 (Crawled : 16:20) - ir.vtvtherapeutics.com
VTVT | $24.74 -0.21% 2K
|
Health Technology
|
| O: -1.02%
H: 1.03%
C: -1.55%
financial results results
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-08-04 (Crawled : 00:00) - prnewswire.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 1.68%
H: 6.92%
C: 4.49%
granted grant pharma
Tarsus Pharmaceuticals, Inc. Reports Second Quarter 2021 Financial Results and Provides Business and Clinical Updates
Published: 2021-08-04 (Crawled : 22:00) - globenewswire.com
TARS | $32.405 -1.36% -1.37% 630K
|
Health Technology
|
| O: -0.13%
H: 6.69%
C: 4.69%
financial results results
T2 Biosystems to Participate in the Canaccord Genuity 41st Annual Growth Conference
Published: 2021-08-04 (Crawled : 22:00) - globenewswire.com
TTOO A | $2.98 -0.33% -0.34% 34K
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: -2.08%
growth conference
Global Proteomics Market Analysis & Forecasts, 2016-2020 & 2021-2026 - Increasing Demand for Personalized Medicine to Bode Well for Market Growth
Published: 2021-08-04 (Crawled : 21:00) - prnewswire.com
WAT | $296.1 0.64% 0.0% 470K
|
Health Technology
|
| O: 0.39%
H: 0.74%
C: 0.39%
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: 0.14%
H: 0.76%
C: 0.35%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: -5.68%
H: 1.98%
C: 1.17%
BRKR | $77.725 -1.06% -1.07% 1.3M
|
Health Technology
|
| O: 0.06%
H: 1.16%
C: -0.47%
growth
Ampio Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-08-04 (Crawled : 21:00) - ampiopharma.com
AMPE | $0.242 0.0% 15K
|
Health Technology
|
| O: 10.74%
H: 14.93%
C: 8.21%
financial results results
Paratek Pharmaceuticals Announces NUZYRA® (omadacycline) Has Been Added to the CDC Plague Guidelines for the Treatment, Pre-Exposure and Postexposure Prophylaxis of Plague
Published: 2021-08-04 (Crawled : 21:00) - globenewswire.com
PRTK | $2.23 0.0% 4.8M
|
Health Technology
|
| O: 3.5%
H: 1.6%
C: -0.71%
treatment plague
Asia-Pacific Cell Therapy Market 2021-2028 - Opportunities in the Approval of Kymriah and Yescarta
Published: 2021-08-04 (Crawled : 20:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: 0.24%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.26%
H: 0.13%
C: -0.36%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.0%
H: 0.13%
C: 0.09%
therapy approval
BioCardia to Participate in a Fireside Chat at the BTIG Virtual Biotechnology Conference on August 10, 2021
Published: 2021-08-04 (Crawled : 20:00) - biospace.com/
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
| O: -2.01%
H: 4.68%
C: 1.46%
biotech technology iot conference
CytomX Therapeutics Announces Multiple Publications on Pacmilimab (CX-072), a Conditionally Activated Inhibitor of Programmed Death-Ligand 1 (PD-L1)
Published: 2021-08-04 (Crawled : 20:00) - biospace.com/
CTMX | $1.67 -3.47% -3.59% 510K
|
Health Technology
|
| O: 0.52%
H: 1.56%
C: -3.29%
Theratechnologies to Present at the Canaccord Genuity 41st Annual Growth Conference
Published: 2021-08-04 (Crawled : 20:00) - biospace.com/
THTX | $1.29 -12.78% 8.1K
|
Health Technology
|
| O: -1.14%
H: 3.46%
C: 2.88%
growth conference
G1 Therapeutics Granted New Technology Add-On Payment (NTAP) for COSELA™ (Trilaciclib) by Centers for Medicare & Medicaid Services (CMS)
Published: 2021-08-04 (Crawled : 20:00) - biospace.com/
GTHX | $4.12 -1.2% -1.21% 730K
|
Health Technology
|
| O: 0.06%
H: 2.38%
C: -0.65%
new technology technology trilaciclib granted grant
Celyad Oncology Reports First Half 2021 Financial Results and Recent Business Highlights
Published: 2021-08-04 (Crawled : 20:00) - celyad.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: -0.94%
H: 1.66%
C: 1.66%
financial results results
F-star Therapeutics Announces Collaboration with MSD to Evaluate FS120 in Combination with KEYTRUDA
Published: 2021-08-04 (Crawled : 20:00) - biospace.com/
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: -1.85%
H: 10.0%
C: 3.58%
collaboration announces collaboration keytruda
Fate Therapeutics Appoints Yuan Xu to its Board of Directors
Published: 2021-08-04 (Crawled : 19:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -0.58%
H: 1.44%
C: -0.61%
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -1.07%
H: 4.32%
C: 4.09%
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: -1.28%
H: 4.38%
C: -2.16%
therapeutics
JAMA Dermatology Publishes Data Showing RINVOQ® (upadacitinib) Achieved Superiority Versus DUPIXENT® (dupilumab) for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis
Published: 2021-08-04 (Crawled : 19:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.4%
H: 0.64%
C: -0.6%
dermatitis phase 3 atopic dermatitis dupixent
Capricor Announces Joint Publication with the US Army Institute of Surgical Research for Cardiosphere-Derived Exosomes as a Potential Therapeutic for Shock
Published: 2021-08-04 (Crawled : 19:00) - biospace.com/
CAPR | $5.01 -0.79% -0.8% 350K
|
Health Technology
|
| O: -1.12%
H: 2.05%
C: -3.18%
potential research cardio
Research Associate I/Research Associate II
Published: 2021-08-04 (Crawled : 18:00) - atyrpharma.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: -1.1%
H: 3.55%
C: 1.56%
research
RNAi Roundtable: Givosiran, for the Treatment of Acute Hepatic Porphyria
Published: 2021-08-04 (Crawled : 18:00) - alnylam.com
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.88%
H: 5.21%
C: 3.5%
treatment hepatitis
Global Nucleic Acid Isolation and Purification Market Report 2021-2031: Evolution of Biobanking in Healthcare / Capitalizing on Genetic Disorders / Adoption of NGS Genetic Tests in Emerging Markets
Published: 2021-08-04 (Crawled : 17:00) - prnewswire.com
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 0.48%
H: 0.38%
C: -0.04%
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: 0.36%
H: 1.06%
C: 0.6%
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: 0.15%
H: 2.45%
C: 2.05%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: 0.06%
H: 0.49%
C: 0.2%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 0.48%
H: 0.38%
C: -0.04%
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: -14.14%
H: 13.09%
C: 12.44%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -0.23%
H: 1.78%
C: 1.47%
genetic test
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.